期刊文献+

CFTR特异性抑制剂治疗腹泻的研究进展 被引量:1

Research Progress in Diarrhea Treatment with Special Inhibitor CFTR
下载PDF
导出
摘要 综述了CFTR特异性抑制剂的作用机制及其在治疗腹泻中的应用研究,并展望了其今后的研究方向及应用前景。 This article summarized the effect mechanism of special inhibitor CFTR and its application studies on diarrhea treatment,and looked forward its research direction and application prospects in the future.
出处 《江西农业学报》 CAS 2011年第7期153-155,共3页 Acta Agriculturae Jiangxi
关键词 囊性纤维化 腹泻 CFTR特异性抑制剂 分子机制 Cystic fibrosis Diarrhea Special inhibitor CFTR Molecular mechanism
  • 相关文献

参考文献15

  • 1Proesmans M,Vermeulen F,De Boeck K. what's new in cystic fi- brosis? From treating symptom to correction of the basic defect [J]. Eur J Pediatr,2008,167(8) ;839 -849. 被引量:1
  • 2Turcios N L. Cystic fibr0sis:an overview[J]. J Clin Gastroenterol, 2005,39(4) :307 -317. 被引量:1
  • 3Sheppard D N, Welsh M J. Structure and function of the CFrR chloride channel [ J ]. Physiol Rev, 1999,79 ( 1 ) :323 - 345. 被引量:1
  • 4Park R W, Grand R J. Related Articles, Gastrointestinal manifes- tations of cystic fibrosis : a review [ J ]. Gastroenterology, 1981,81 (6) :1143 - 1161. 被引量:1
  • 5袁静.几种仔猪常见腹泻病鉴别及防治[J].中国畜禽种业,2009,5(11):81-83. 被引量:2
  • 6Gunderson K L,Kopito R R. Effect of pyrophosphare and nucleo- tide analogs suggest a role for ATP hydrolysis in cystic fibrosis transmembrane conductance regulator channel gating [ J ]. J Biol Chem,1994,269(30) :19349 - 19353. 被引量:1
  • 7赵露..CFTR Cl<'->通道和GlpF甘油通道调节剂的高通量筛选研究[D].东北师范大学,2004:
  • 8Thiagarajah J R, Song Y, Haggie P M, et al. A small molecule CFTR inhibitor produces cystic fibrosis - like submucosal gland fluid secretions in normal airways [ J ]. FASEB J,2004,18 (7) :875 -877. 被引量:1
  • 9Thiagarajah J R, Broadbent T, Hsich E, et al. Prevention of toxin - induced intestinal ion and fluid secretion by a small - molecule CFTR inhibitor[J]. Gastroenterology ,2004,126(2) :511 -519. 被引量:1
  • 10Thiagarajah J R,Verkman A S. CFTR pharmacology and its role intestinal fluid secretion[ J]. Current Opinion in Pharmacology, 2003,3(6) :594 -599. 被引量:1

二级参考文献28

  • 1许文杰,丁启龙.黄芩素的药理学研究进展[J].江苏药学与临床研究,2006,14(2):103-107. 被引量:49
  • 2Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA [ J ]. Science, 1989, 245 ( 4922 ) : 1066- 1073. 被引量:1
  • 3Robert R, ThoreauV, Norez C, et al. Regulation of the cystic fibrosis transmembrane conductance regulator channel by β-adrenergic agonists and vasoactive intestinal peptide in rat smooth muscle cells and its role in vasotelaxation[J]. J Biol Chem, 2004,279(20):21100- 21168. 被引量:1
  • 4RobertR, Norez C, Becq F. Disruption of CFTR chloride channel alters mechanical properties and cAMP-dependent Cl^- transport of mouse aortic smooth muscle cells [ J ]. J Hysiol, 2005,568(2) :483 - 495. 被引量:1
  • 5Ichimura T, Yamanaka A, Ichiba T, et al. Antihypertensive effect of an extract of Passiflora edulis rind in spontaneously hypertensive rats[J]. Biosci Biotechnol Biochem, 2006,70(3) :718 - 721. 被引量:1
  • 6Jiang H, Xia Q, Wang X, et al. Luteolin induces vasorelaxion in rat thoracic aorta via calcium and potassium channels[ J ]. Pharmazie, 2005,60(6) :444 - 447. 被引量:1
  • 7Duarte J, Perez Vizcaino F, Utrilla P, et al. Vasodilatory effects of flavonoids in rat aortic smooth muscle Structureactivity relationships[J]. Gen Pharmacol, 1993,24(4) : 857 - 862. 被引量:1
  • 8Hwang TC, Wang F, Yang IC, et al. Genistein potentiates wild-type and delta F508-CFTR channel activity[J]. Am J Physiol, 1997,273( 3 Pt 1 ) : C988 - 998. 被引量:1
  • 9Galietta LV, Jayaraman S, Verkman AS. Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists [ J]. Am J Physiol Cell Physiol, 2001, 281(5) :C1734- 1742. 被引量:1
  • 10Ma T, Vetrivel L, Yang H, et al. High-attinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening[J]. J Biol Chem, 2002,277(40):37235- 37241. 被引量:1

共引文献5

同被引文献21

  • 1Zolnerciks JK, Andress EJ, Nicolaou M, et al. Structure of ABC transporters[ J]. Essays Biochem,2011,50( 1 ) : 43-61. 被引量:1
  • 2Rosenberg MF, O' ryan LP, Hughes G, et al. The cystic fibrosis transmembrane conductance regulator ( CFTR ) : three-dimensional structure and localization of a channel gate[ ] ]. J Biol Chem,201 1, 286 (49) : 42647-42654. 被引量:1
  • 3Atwell S, Brouillette CG, Conners K, et al. Structures of a minimal human CFTR first nucleotide-binding domain as a monomer, head-to- tall homodimer, and pathogenic mutant [J]. Protein Eng Des Sel, 2010, 23(5) : 375-384. 被引量:1
  • 4Thiagarajah J , Verkman A. CFTR inhibitors for treating diarrheal disease [ J ]. Clin Pharmacol Ther, 2012, 92 ( 3 ) : 287-290. 被引量:1
  • 5Verkman AS, Synder D, Tradtrantip L, et al. CEFR Inhibitors [ J ]. Current Pharmaceutical Design ,2013, 19(19) : 3529-3541. 被引量:1
  • 6Venkatasubramanian J, Ao M, Rao MC. Ion transport in the small intestine[ J]. Curr Opin Gastroen,2010, 26(2) : 123-128. 被引量:1
  • 7Hoque KM, Woodward OM, Van Rossum DB, et al. Epael mediates protein kinase A-indepeNdent mechanism of forskolin-aetlvated intes- tinal ehloride secretion[ J]. J Gen Ph3~sio1,2010, 135 (1) : 43-58. 被引量:1
  • 8Kopeikin Z, Sohma Y, Li M, et al. on the mechanism of CFTR inhi- bition by a thiazolidinone derivative [ J ]. J Gen Physiol, 2010, 136 (6) : 659-671. 被引量:1
  • 9Melis N, Tanc M, Cougnon M, et al. Revisiting CFTR inhibition: a comparative study of CTTRinh -172 and GlyH-101 inhibitors[J]. Br J Phacol,2014, 171 (15) : 3716-3727. 被引量:1
  • 10Snyder DS, Tradtrantip L, Yao C, et al. Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-diane (BPO) CFI'R inhibitors for polycystic kidney disease [ J ]. J Med Chem, 2011, 54 ( 15 ) : 5468- 5477. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部